Quantcast

Latest 17-Hydroxyprogesterone Stories

2014-05-29 08:30:13

ST. LOUIS, May 29, 2014 /PRNewswire-USNewswire/ -- K-V Pharmaceutical Company today announced a new corporate name, Lumara Health Inc., which reflects the fundamental changes the Company has made since emerging from Chapter 11 bankruptcy protection last year to align with its core mission of helping women achieve healthier lives. "With new ownership, a new Board of Directors with a strong and diverse background in healthcare, new members of our leadership team who bring deep expertise that...

2013-06-19 23:19:35

McGuff Pharmaceuticals, Inc. (MPI) continues to pursue the approval of an Abbreviated New Drug Application (ANDA) for Hydroxyprogesterone Caproate Injection, USP 250mg/mL, 5mL, multiple dose vial; a generic version of Bristol-Myers Squibb´s drug formerly known as Delalutin. While McGuff Pharmaceuticals can not predict when the FDA will complete its review, MPI remains committed to bringing the drug product to market as quickly as possible. Santa Ana, CA (PRWEB) June 19, 2013 McGuff...

2013-02-11 13:33:21

March of Dimes Award abstract In a study to be presented on February 14 between 8 a.m. and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's 33rd annual meeting, The Pregnancy Meeting , researchers will report findings that suggest that 17P, a form of progesterone, is not effective in preventing preterm birth among women with twin pregnancies – and may possibly be harmful. While 17P (17 alpha-hydroxyprogesterone caproate) has been shown to prevent premature delivery among...

2012-02-09 13:14:15

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting , in Dallas, Texas, researchers will report findings that indicate that prescription medications may affect the body's ability to metabolize 17-alpha-hydroxyprogesterone caproate (17-OHPC), the only FDA approved medication for the prevention of recurrent preterm birth. While 17-OHPC is routinely prescribed, much is still unknown about how it works. Studies have shown a large...

2011-02-11 14:07:37

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting â“ž¢, in San Francisco, researchers will present findings that show that when women at high risk for preterm birth participated in a preterm birth prevention clinic, more women delivered full term babies and there were fewer cases of infant morbidity. The National Center for Health Statistic reports that in 2008, 12.3% of babies were born...

2011-02-10 12:29:39

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting â“ž¢, in San Francisco, researchers will present findings that show that the use of the hormone 17-Hydroxyprogesterone does not reduce the rate of preterm delivery or neonatal complications in twins. The hormone 17-Hydroxyprogesterone is sometimes used to reduce the risk of preterm labor. In 2008, the American College of Obstetricians and...

2009-01-29 23:01:00

March of Dimes Awards Abstract at SMFM Meeting. SAN DIEGO, Jan. 30 /PRNewswire-USNewswire/ -- New research that may explain why taking progesterone to prevent preterm birth is only effective for some women was unveiled today at the 29th Annual Society for Maternal-Fetal Medicine (SMFM) meeting - The Pregnancy Meeting(TM). The drug, 17 alpha-hydroxyprogesterone caproate (or 17P), a synthetic form of the progesterone hormone naturally produced during...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related